Local Institution

Sakai, Osaka 591-8555

0 studies enrolling now · 2 studies all time

What they study most

Acute Coronary Syndrome, Non-Small-Cell Lung Carcinoma

Studies at this site

• A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy — Completed
• Phase III Acute Coronary Syndrome — Stopped early